Clinical Trial Update: Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

This is an update on a Phase 2 trial evaluating capecitabine and oxaliplatin with or without cetuximab for metastatic colorectal cancer that cannot be removed b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED